PRODUCT INFORMATION
Description
CSTSMLKAC (Cys-Ser-Thr-Ser-Met-Leu-Lys-Ala-Cys) is a cyclic nine-amino-acid peptide (Cys1-Cys9 disulfide bridge) that mimics an endogenous sequence. It has been reported to specifically home to cardiomyocytes within the ischemic myocardium in animal models. This makes it a candidate for in vitro and in vivo research into cardiac-targeted molecular delivery strategies.
Molecular Weight
941.15
Purity
> 95%
Formula
C₃₆H₆₄N₁₀O₁₃S₃
Product Type
Targeting Peptide
Sequence
Cys-Ser-Thr-Ser-Met-Leu-Lys-Ala-Cys (Disulfide bridge: Cys1-Cys9)
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(RADfK) Targeting Peptide (CAT#: OLY-1025-YS-61)
- FFAGLDD TFA Targeting Peptide (CAT#: OLY-1025-YS-49)
- mUNO Targeting Peptide (CAT#: OLY-1025-YS-29)
- LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
- VSLRGDTRG Targeting Peptide (CAT#: OLY-1025-YS-32)
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- Rabies Virus Matrix Protein Fragment (RV-MAT) (CAT#: OLY-1025-YS-14)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.